The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity

Por Wise, T N, Wiltse, C G, Iosifescu, D V, Sheridan, M, Xu, J Y, Raskin, J
Publicado em 2007

Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder

Por Murrough, J W, Collins, K A, Fields, J, DeWilde, K E, Phillips, M L, Mathew, S J, Wong, E, Tang, C Y, Charney, D S, Iosifescu, D V
Publicado no Transl Psychiatry (2015)

Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome

Por Kiraly, D D, Horn, S R, Van Dam, N T, Costi, S, Schwartz, J, Kim-Schulze, S, Patel, M, Hodes, G E, Russo, S J, Merad, M, Iosifescu, D V, Charney, D S, Murrough, J W
Publicado no Transl Psychiatry (2017)

Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression

Por Haile, C. N., Murrough, J. W., Iosifescu, D. V., Chang, L. C., Jurdi, R. K. Al, Foulkes, A., Iqbal, S., Mahoney, J. J., De La Garza, R., Charney, D. S., Newton, T. F., Mathew, S. J.
Publicado em 2013

Using electronic medical records to enable large-scale studies in psychiatry: treatment resistant depression as a model

Por Perlis, R. H., Iosifescu, D. V., Castro, V. M., Murphy, S. N., Gainer, V. S., Minnier, J., Cai, T., Goryachev, S., Zeng, Q., Gallagher, P. J., Fava, M., Weilburg, J. B., Churchill, S. E., Kohane, I. S., Smoller, J. W.
Publicado em 2011